Community post
Adaptive Phage Therapeutics will be collaborating with Oyster Point Pharma (Nasdaq: OYST) to develop therapies to target multiple opthalmic diseases using APT’s PhageBank™ technology.
Topics
| Source | Capsid & Tail #130 |
|---|
Adaptive Phage Therapeutics will be collaborating with Oyster Point Pharma (Nasdaq: OYST) to develop therapies to target multiple opthalmic diseases using APT’s PhageBank™ technology.
| Source | Capsid & Tail #130 |
|---|